For help with a story, contact Charles Siler at (602) 633-8960 or email@example.com.
STATE LAWMAKERS IN THREE STATES VOTE UNANIMOUSLY TO ALLOW TERMINAL PATIENTS EXPERIMENTAL DRUG ACCESS, CUT FDA RED TAPEPosted on April 02, 2014 | Type: Press Release
State representatives in Colorado, Louisiana and Missouri all voted unanimously this week to approve an unprecedented measure to empower terminally ill patients to access experimental drugs that could save their lives but have not yet been approved for market by the FDA.
BREAKING NOW: ARIZONA SUPREME COURT DENIES TEACHERS’ UNION APPEAL, UPHOLDS NEXT FRONTIER EDUCATION SAVINGS ACCOUNT PROGRAMPosted on March 21, 2014 | Type: Press Release
Ruling paves way for education savings accounts throughout the country, even where vouchers have been rejected
FOR IMMEDIATE RELEASE: GA LAWMAKERS GREENLIGHT ARTICLE V BALANCED BUDGET AMENDMENT CONVENTIONPosted on March 19, 2014 | Type: Press Release
The Peach State is poised to be the first to pass the Compact for a Balanced Budget
MEDIA ADVISORY: UNION, CITY ALLIES ASKS JUDGE TO APPROVE EXTRA 16,000 HOURS OF VACATION TIME FOR UNION BUSINESSPosted on March 06, 2014 | Type: Press Release
Following a January court ruling declaring taxpayer-funded union activism in public labor contracts unconstitutional, a police union in Phoenix is asking a judge to bless a scheme that would dole out an additional 1,000 hours per week of vacation to use on whatever union members want--chiefly, union business.
FOR IMMEDIATE RELEASE: MO LAWMAKERS TO GREEN-LIGHT “RIGHT TO TRY” LIFE-SAVING MEDICATIONS BILL WEDNESDAYPosted on February 26, 2014 | Type: Press Release
The reform, known as the “Right to Try” Act, would empower terminally ill patients under the care of licensed doctors to access experimental drugs that have passed basic safety tests but whose efficacy is not yet conclusive. Currently, it takes nearly a decade and up to $1 billion to shepherd life-saving treatments through the FDA approval process—time the sickest Americans simply do not have to wait.